Stage II Breast Cancer Active Not Recruiting Phase 2 Trials for Trastuzumab emtansine (DB05773)

IndicationStatusPhase
DBCOND0029484 (Stage II Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02414646Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast CancerTreatment
NCT02326974T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCATreatment